Please login to the form below

Not currently logged in
Email:
Password:

merger

This page shows the latest merger news and features for those working in and with pharma, biotech and healthcare.

Shire rebuffs Takeda bids, as Allergan bows out

Shire rebuffs Takeda bids, as Allergan bows out

Allergan - also headquartered in Ireland - is no stranger to the M&A game having been bulked up by serial acquisitions in recent years, including a $66bn merger with Actavis in 2014

Latest news

More from news
Approximately 84 fully matching, plus 420 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 73 fully matching, plus 35 partially matching documents found.

Latest appointments

  • Ipsen bolsters leadership team Ipsen bolsters leadership team

    With expertise in corporate partnering, mergers and acquisitions, pipeline and product portfolio development, legal and IP strategy, Magovcevic-Liebisch has worked in several management roles including executive vice president and chief

  • IRX Therapeutics appoints Luba Greenwood to its board IRX Therapeutics appoints Luba Greenwood to its board

    Her career has spanned leadership roles in venture investing, business development, mergers and acquisitions, law, consulting and operations. ... Prior to that, she served as senior mergers and acquisitions counsel at Pfizer.

  • Reig Jofre boosts Forté Pharma’s senior team Reig Jofre boosts Forté Pharma’s senior team

    Ignasi Biosca, chief executive officer, Reig Jofre, said: “We had been working for some time on Forté Pharma's development plan after the merger with Natraceutical, and I am convinced that

  • Reig Jofre appoints Alejandro Reig as vice president Reig Jofre appoints Alejandro Reig as vice president

    He most recently took the director position at Reig Jofre after its merger with Natraceutical in December 2015.

  • Apeiron bolsters management board Apeiron bolsters management board

    With more than 25 years’experience in initial public offerings, mergers and acquisitions, as well as licensing and financial transactions in the chemical, biotech and pharma industries, Llewellyn-Davies most recently

More from appointments
Approximately 0 fully matching, plus 48 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 27 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CAN advertising

Brief us and you’ll soon see we really CAN do it all. We’re different to other agencies. You’ll get expert...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics